Discover 225 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 225
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: Ames IA, Omaha NE, Lincoln NE, Kansas City MO,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes and an A1C Between 7% and 10.5%
for
Diabetes Mellitus, Type 2
Location: Ames IA, Omaha NE, Kansas City MO, Minneapolis MN,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Heart Disease or Heart Risk Factors
for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Ames IA, Omaha NE, Kansas City MO, Melrose Park IL,
Sex: All
Age: 18+
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Des Moines IA, Lincoln NE, Topeka KS, Jefferson City MO,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Des Moines IA, Iowa City IA, Rochester MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT00736749
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Des Moines IA, La Crosse WI, Brewer ME
Sponsor: PrECOG, LLC.
Sex: All
Age: 18 - 70+
Code: NCT07285239
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Des Moines IA, Clive IA, Ankeny IA, Waukee IA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Des Moines IA, Clive IA, Ankeny IA, Waukee IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase 2, Phase 3, Recruiting
Active & Responsive
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Des Moines IA, Ames IA, Iowa City IA, Omaha NE,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Des Moines IA, Clive IA, Pella IA, West Des Moines IA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase 3, Recruiting
Active & Responsive
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Des Moines IA, West Des Moines IA, Clive IA, Ankeny IA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07283939
Recruiting
Active & Responsive
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Des Moines IA, Clive IA, Pella IA, West Des Moines IA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07091617
Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study